|1|A Novel Splice Site Mutation in the Non-coding Region of BRCA2: Implications for Fanconi Anemia and Familial Breast Cancer Diagnostics. (24395671)
Bakker J.L.... Waisfisz Q.
|2|Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. (24081944)
Collins I.M.... Phillips K.A.
|3|Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population. (23289006)
Laraqui A.... Bignon Y.J.
|4|Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry. (24097051)
Walker M.J.... Chiarelli A.M.
|5|Validation, calibration and refitting of a familial breast cancer model in sisterships: a case study in the Swedish sisters data. (23508778)
van Houwelingen H.C.... Reilly M.
|6|The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. (22415478)
Catucci I.... Peterlongo P.
|7|Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer. (20848184)
Lheureux S.... Hardouin A.
|8|A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history. (20878484)
PisanA^ M.... Tinelli A.
|9|Old and new concepts in histopathological characterization of familial breast cancer. (21285147)
Mangia A.... Darvishian F.
|10|An intronic mutation in MLH1 associated with familial colon and breast cancer. (20717847)
Bianchi F.... Cellerino R.
|11|RAD51C germline mutations in Chinese women with familial breast cancer. (21597919)
Pang Z.... Xie Y.
|12|Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients. (20676758)
Hautala L.C.... Nevanlinna H.
|13|An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature. (18500673)
Pal S.K.... Somlo G.
|14|Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. (18563556)
Bane A.L.... Andrulis I.L.
|15|Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk. (19229607)
Yang R.... Burwinkel B.
|16|Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report. (19051060)
Syamala V.S.... Ankathil R.
|17|Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases. (18327210)
Colombo M.... Radice P.
|18|Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. (18071313)
Melchor L.... BenA-tez J.
|19|Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers. (18381935)
Aaltonen K.... Nevanlinna H.
|20|Tissue microarrays for testing basal biomarkers in familial breast cancer cases. (17992394)
Dufloth R.M.... Zeferino L.C.
|21|Study on gene control region of mitochondrial DNA in familial breast cancer]. (17922420)
Zhou Y.L.... Shi Y.R.
|22|Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. (17016484)
Griebsch I.... Leach M.O.
|23|Evaluation of RAD50 in familial breast cancer predisposition. (16385572)
Tommiska J.... Rahman N.
|24|What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. (15834241)
van Dijk S.... Kievit J.
|25|BRCA1 and BRCA2 mutations in patients with familial breast cancer]. (15683621)
Bolufer P.... BarragA!n E.
|26|Differences in individual approaches: communication in the familial breast cancer consultation and the effect on patient outcomes. (15789155)
Lobb E.A.... Tucker K.
|27|Feeling at risk: how women interpret their familial breast cancer risk. (15382029)
van Dijk S.... Kievit J.
|28|Costs and benefits of diagnosing familial breast cancer. (15280189)
MA... ller P.
|29|Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer. (12624724)
Sakayori M.... Ishioka C.
|30|Contributions of ATM mutations to familial breast and ovarian cancer. (12810666)
Thorstenson Y.R.... Oefner P.J.
|31|Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk. (12793891)
Varley J.... Haber D.A.
|32|BRCA1 and BRCA2 mutations in Russian familial breast cancer. (11793480)
Tereschenko I.V.... Pharoah P.D.
|33|Oral contraceptives and risk of familial breast cancer. (12088199)
Heimdal K.... ller P.
|34|A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. (11857015)
Antoniou A.C.... Easton D.F.
|35|BRCA2 gene mutations in Greek patients with familial breast cancer. (11754111)
Armakolas A.... Androulakis G.
|36|Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer. (10885601)
Gershoni-Baruch R.... Friedman E.
|37|Management of familial breast cancer risk. (10989983)
|38|Familial breast cancer: the problems of circumstantial evidence. (11315714)
|39|A comparison of methods currently used in clinical practice to estimate familial breast cancer risks. (10847465)
Tischkowitz M.... Gray J.
|40|The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology. (11250683)
Lalloo F.... Evans D.G.
|41|The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology? (11250682)
Bertwistle D.... Ashworth A.
|42|Genes responsible for familial breast cancer. (8880869)
Cornelisse C.J.... Devilee P.
|43|The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. (8895736)
Panagopoulos I.... Aman P.
|44|Serum p53 auto-antibodies: incidence in familial breast cancer. (8080669)
Green J.A.... Robertson L.
|45|Familial breast cancer risks. Effects of prostate and other cancers. (8508396)
Anderson D.E.... Badzioch M.D.
|46|Occurrence of a fetal fibroblast phenotype in familial breast cancer. (3710614)
Schor S.L.... Crowther D.
|47|Blood type A and familial breast cancer. (6478419)
Anderson D.E.... Haas C.
|48|Familial breast cancer in Iceland. (7085127)
Tulinius H.... Grimsdottir K.
|49|Endocrine profile in a patient with familial breast cancer: a case-control study. (498052)
Lynch H.T.... Maloney K.
|50|Management of familial breast cancer. I. Biostatistical-genetic aspects and their limitations as derived from a familial breast cancer resource. (687103)
Lynch H.T.... Lynch J.F.